Hot Topics in HCV
A Multidisciplinary Online Mini-Curriculum
Clinical Practice Guidelines
CDC Recommendations for Hepatitis C Screening Among Adults in the United States.
Centers for Disease Control and Prevention (CDC). Last reviewed July 2020.
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
American Association for the Study of Liver Diseases (AASLD). March 2021.
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.
American Association for the Study of Liver Diseases (AASLD/Infectious Diseases Society of America (IDSA), Last updated March 2021.
Simplified HCV Treatment Algorithm for Treatment-Naive Adults Without Cirrhosis.
American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA). Last updated August 2020.
Clinical Resources
Hepatitis C Online Tools and Calculators: APRI
Hepatitis C Online: University of Washington.
Hepatitis C Online Tools and Calculators: FIB-4
Hepatitis C Online: University of Washington.
HEP Drug Interactions
University of Liverpool.
National Harm Reduction Coalition
Action and Advocacy: National HCV Resources
Center for Health Law and Policy Innovation (CHLPI)
CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.
Hepatitis Education Project (HEP)
HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.
National Viral Hepatitis Roundtable
National Viral Hepatitis Roundtable (NVHR) is a coalition working together to eliminate hepatitis B and C in the U.S. It offers practical online resources for practice management.
Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map
SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.
Patient Resources
Hepatitis C Information Center
American Liver Foundation.
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created to support individuals impacted by HCV infection.
Hepatitis C Questions and Answers for the Public
Centers for Disease Control and Prevention (CDC). Last reviewed July 2020.
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.
Suggested Readings
Impact of COVID-19 on global HCV elimination efforts.
Blach S, et al. J Hepatol. 2021;74(1):31-36.
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.
Chappell CA, et al. Lancet Microbe. 2020;1:e200-208.
Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy.
Kushner T, Reau N. J Hepatol. 2021;74(3):734-741.
Development of an interdisciplinary telehealth model of provider training and comprehensive care for hepatitis C and opioid use disorder in a high-burden region.
Sherbuk JE, et al. J Infect Dis. 2020;222(Suppl 5):S354-S364.
The impact of COVID-19 on vulnerable populations and implications for children and health care policy.
Siegal RM, Mallow PJ. Clin Pediatr (Phila). 2020;60(2):93-98.
Minimal monitoring of treatment for hepatitis C virus infection.
Sulkowski M. Gastroenterol Hepatol. 2020;17(5):230-232.
A framework for patient-centered telemedicine: application and lessons learned from vulnerable populations.
Talal AH, et al. J Biomed Inform. 2020;112:103622
SARS-CoV-2 infection and the liver.
Morgan K, et al. Pathogens. 2020;9(6):430.
Module 2
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience
A Focus on Clinical Evidence and Guideline Recommendations
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
A Multidisciplinary Look at Early Diagnosis and Management
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
